AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

BRAVE BISON GROUP PLC

Transaction in Own Shares Dec 19, 2025

7530_sha_2025-12-19_3de2fb8c-6a91-4d88-bfe7-8669f463bb02.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 1311M

Brave Bison Group PLC

19 December 2025

Brave Bison Group plc

("Brave Bison" or the "Company", together with its subsidiaries "the Group") 

Update on Issue of Equity

Brave Bison, the next-generation marketing and technology partner for global brands, announces that further to the announcement made on 12 December 2025, Admission of the 202,451 new Ordinary Shares pursuant to the exercise of options by certain Group employees will now take place on 23 December 2025. All other details remain unchanged.

For further information please contact: 

Brave Bison Group plc 

Oliver Green, Chairman                                                                          via Cavendish

Theo Green, Chief Growth Officer 

Philippa Norridge, Chief Financial Officer 

Cavendish Capital Markets                                                                     Tel: +44 (0) 20 7220 0500 

Nominated Adviser & Joint Broker  

Ben Jeynes / Teddy Whiley / Elysia Bough - Corporate Finance 

Michael Johnson / Sunila de Silva - ECM 

Singer Capital Markets                                                                              Tel: +44 (0) 20 7496 3000

Joint Broker

Alex Hardwicke

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

IOEFLFVIFILTLIE

Talk to a Data Expert

Have a question? We'll get back to you promptly.